Transcept Pharmaceuticals to Present at the BioCentury 'Future Leaders in the Biotech Industry' ...( PT. RICHMOND Calif. March 19 /- T...),Health
Navigation Links
Transcept Pharmaceuticals to Present at the BioCentury 'Future Leaders in the Biotech Industry' Conference
Date:3/19/2008
PT. RICHMOND, Calif., March 19 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, Chief Executive Officer & President, will present at the BioCentury "Future Leaders in the Biotech Industry" Conference at the Millennium Broadway Hotel & Conference Center in New York City on Thursday, March 27, 2008 at 9:30 AM Eastern Time.
About Transcept Pharmaceuticals
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company
deriving significant new patient benefits from proven CNS drugs. Transcept
development projects leverage new understanding of CNS conditions to
provide additional uses and enhanced clinical benefits for existing active
agents. The lead Transcept product candidate, Intermezzo(R) (zolpidem
tartrate lozenge), is a low dose sublingual formulation of zolpidem for the
treatment of insomnia in patients who awaken in the middle of the night and
have difficulty returning to sleep. Phase 3 clinical trials have been
completed for Intermezzo(R) and Transcept plans to submit an NDA in the
third quarter of 2008. Transcept is also developing TO-2060, a novel,
fixed-dose combination of olanzapine and ondansetron for the treatment of
dopamine associated psychiatric disorders. For further information, please
visit the company's website at: http://www.transcept.com.
Contacts:
Transcept Pharmaceuticals, Inc.
Michael Gill
Director of Communications
(510) 215-3575
The Ruth Group
Investors / Media
Stephanie Carrington / Jason Rando
(646) 536-7017 / 7025
'/>"/>
| SOURCE Transcept Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
2. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
3. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
4. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
6. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
7. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
10. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
11. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
Post Your Comments:
(Date:11/21/2008)...B.C., a new and deadly diseaseits cause remains a ...ate was teeming with citizens, soldiers and refuge...a. As streets filled with corpses, social order br...eturned twice and Athens lost a third of its popul...arked the beginning of the end of the Golden Age o...
(Date:11/21/2008)...nd., Nov. 21 Symmetry Me...rovider of products to the global orthopedic devic...day that Brian S. Moore, President and Chief Execu...ent and Chief Financial Officer, are scheduled to ...re Conference at The New York Palace Hotel on Wedn...
(Date:11/21/2008)...PRING HARBOR, N.Y. (Nov. 21, 2008) How can moss ...e lamprey immune system tell us about evolution? ... with efforts to conserve rare species? What can ...d hereditary diseases? Will studies of choanoflag...wer these and other questions in biology, scientis...
(Date:11/21/2008)...ES, Nov. 21 In a recent announceme...g the Sales and Use Tax to include,"luxury" items...se an increase,in animal shelter overpopulation. ...ining forces and urging all pet owners to take act...e to stop this tax. , "Our companion animal...
Breaking Medicine News(10 mins):Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:A new world of research possibilities with 'Emerging Model Organisms' 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3[0] Study of ancient and modern plagues finds common features[0] Symmetry Medical to Present at 20th Annual Piper Jaffray Healthcare Conference[0] A new world of research possibilities with 'Emerging Model Organisms'[0] A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation
... cut the price of efavirenz 600mg tablets (Stocrin...cess programme//, the company announced yesterday....ally, it will make the branded version of efaviren...iland, where a compulsory license was recently iss...
...arden trampoline is a fun form of exercise and pla...and youths// than traffic, according to a new Swed...uries was of concern "especially due to neck and h...jornstig of the Umea University Hospital in northe...
...e literally found the needle in the haystack as ye...logy coupled// to help to discover hitherto unknow...ery expected to do much in the prevention and trea...ith considerable excitement and speculation. Scie...
...failure (CHF) patients in rural and remote areas o...and support services//, according to health resear...ecently hospitalised patients to help optimise the...ey leave the hospital. But according to Ms Robyn...
Other Medicine News:Health News:New Gene Linked to Autism Discovered 2(Date:11/13/2008)...Study Suggests Nutritional Supplements Prior to Su...re-USNewswire/ -- Identifying,malnutrition before ...dy,contouring will significantly decrease surgical...scar quality and boost patient energy levels,acco...and Reconstructive,Surgery(R), the official medica...
(Date:11/12/2008)...YORK, Nov. 12 A new stu... of Cell will help answer the,question, what cause...questions in the medical research into,Parkinson,s... brain to die,in the first place. Answering this q...e are two nearly identical types of brain cells th...
(Date:11/12/2008)...ELAND, Ohio and LOD, Israel, November 12 /PRNewswi...ical Center, NY indicated that,patient-specific CT...or,(ANGIO Mentor(TM), Simbionix US) with high face... simulation improved the operative flow,increased...decreased,overall operative and fluoroscopy time a...
(Date:11/12/2008)...ata from Open Label Study and New Data Suggesting ...at ACAAI 2008 Annual Meeting -, EXTON, Pa., Nov. ...ed,(Nasdaq: VPHM ) today announced the presentati...wing that in this study Cinryze(TM) C1 inhibitor,t...editary angioedema (HAE),attacks seen in the study...
Breaking Medicine Technology:Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Embolization a Nonsurgical Way to Treat Fibroids 14658 1Embolization a Nonsurgical Way to Treat Fibroids 14658 2Embolization a Nonsurgical Way to Treat Fibroids 14658 3Eating Disorders Take Center Stage at iaedp 28TM 29 2008 Symposium in Orlando Florida 14657 1Eating Disorders Take Center Stage at iaedp 28TM 29 2008 Symposium in Orlando Florida 14657 2Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference 14655 1Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference 14655 2Insmed Announces Additional Information in Compliance With NASDAQ Rules 4064 1Insmed Announces Additional Information in Compliance With NASDAQ Rules 4064 2...RNewswire-FirstCall/ -- Sunesis Pharmaceuticals, I...data from ongoing clinical,studies of SNS-595 and ...ology Association (EHA) being held June 7-10, 2007...updated interim data from the,company,s Phase 1 cl...l as clinical data from an ongoing study of SNS-03...
...s delighted to,inform you about the upcoming scien... CYT003-QbG10 to treat allergic diseases.,Recently...obtained,and will be presented in different sessio... Allergology and Clinical Immunology,(EAACI), taki...eden. The EAACI Congress has developed into one of...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2Take Performance to a Higher Level.
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC).
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic
... is used to seal the arterial puncture site. Duett...iotomy and the tissue tract with a flowable procoa...r and procoagulant - the Duett sealing device is d...he Duett is unique in its ability to quickly seal ...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |